Insulet Corp
PODD: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|<V | LOCK|n%Hq^ | LOCK|&jz?>g$ |
Insulet Earnings: Stellar Finish to 2025 With Strong Fourth Quarter
Insulet delivered fourth-quarter revenue growth of 29% in constant currency, fueled by 42% growth outside the US. Quarterly operating margin also expanded by 40 basis points. Shares rose by about 8% in early trading.
